Expertise in
2
conditions

Dr. Jeffrey I. Stewart

Intensive Care Medicine
Mary Hitchcock Memorial Hospital
1 Medical Center Dr, 
Lebanon, NH 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
2
conditions
Mary Hitchcock Memorial Hospital
1 Medical Center Dr, 
Lebanon, NH 

Overview

Jeffrey Stewart is an Intensive Care Medicine provider practicing medicine in Lebanon, New Hampshire.

Dr. Stewart is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Emphysema, Pulmonary Fibrosis, Lung Nodules, and Venous Thromboembolism (VTE).

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 5 clinical trials. Dr. Stewart is currently accepting new patients.

Specialties

Intensive Care Medicine

Licenses

Critical Care Medicine in PA

Hospital Affiliations

Mary Hitchcock Memorial Hospital
Alice Peck Day Memorial Hospital
New London Hospital
Rutland Regional Medical Center
Cheshire Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
NH Healthy Families
  • EPO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Mary Hitchcock Memorial Hospital
1 Medical Center Dr, Lebanon, NH 03756

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Completed
Publish Date: May 05, 2026
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis or Sarcoidosis on Long Term Oxygen Therapy Followed by an Optional Open-Label Long Term Extension Safety Study
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed, Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis or Sarcoidosis on Long Term Oxygen Therapy Followed by an Optional Open-Label Long Term Extension Safety Study
Enrollment Status: Completed
Publish Date: August 10, 2022
Intervention Type: Combination product
Study Drug: iNO
Study Phase: Phase 2
View 4 Less Clinical Trials

9 Total Publications

Value of pulmonary function testing identifying progressive pulmonary disease in fibrotic sarcoidosis: results of a prospective feasibility study.
Value of pulmonary function testing identifying progressive pulmonary disease in fibrotic sarcoidosis: results of a prospective feasibility study.
Journal: Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
Published: February 22, 2022
Similar Doctors
Expertise in
2
conditions
Dr. David J. Feller-Kopman
Intensive Care Medicine
Expertise in
2
conditions
Dr. David J. Feller-Kopman
Intensive Care Medicine
Referral may be required
Before you request

Mary Hitchcock Memorial Hospital

1 Medical Center Dr, 
Lebanon, NH 
 (0.1 miles away)
603-650-5533
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Feller-Kopman is an Intensive Care Medicine provider practicing medicine in Lebanon, New Hampshire. Dr. Feller-Kopman is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Lung Nodules, ALK-Positive Non-Small Cell Lung Cancer, Emphysema, Endoscopy, and Tissue Biopsy. Dr. Feller-Kopman is currently accepting new patients.

Expertise in
1
conditions
Dr. Alex H. Gifford
Intensive Care Medicine
Expertise in
1
conditions
Dr. Alex H. Gifford
Intensive Care Medicine
Referral may be required
Before you request

Mary Hitchcock Memorial Hospital

1 Medical Center Dr, 
Lebanon, NH 
 (0.1 miles away)
603-650-5533
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alex Gifford is an Intensive Care Medicine provider practicing medicine in Lebanon, New Hampshire. Dr. Gifford is highly rated in 1 condition, according to our data. His clinical expertise encompasses Secondary Immunodeficiency (SID), Nontuberculous Mycobacterial Lung Disease, Emphysema, and Lung Nodules. Dr. Gifford is currently accepting new patients.

Expertise in
1
conditions
Dr. Kylene E. Halloran
Intensive Care Medicine
Expertise in
1
conditions
Dr. Kylene E. Halloran
Intensive Care Medicine
Referral may be required

Mary Hitchcock Memorial Hospital

1 Medical Center Dr, 
Lebanon, NH 
 (0.2 miles away)
603-650-4249
Experience:
17+ years
Languages Spoken:
English

Kylene Halloran is an Intensive Care Medicine provider practicing medicine in Lebanon, New Hampshire. She has been practicing medicine for over 17 years. Dr. Halloran is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Schizoaffective Disorder.

Frequently Asked Questions about Dr. Jeffrey I. Stewart

How do I make an appointment with Dr. Jeffrey I. Stewart?

You can book an appointment with Dr. Jeffrey I. Stewart by calling their office at 603-650-2929. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jeffrey I. Stewart a top-rated expert for Emphysema?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey I. Stewart is classified as an Advanced expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jeffrey I. Stewart specialize in?

While Dr. Jeffrey I. Stewart is a Intensive Care Medicine, they have specific expertise in Emphysema, Pulmonary Fibrosis, and Lung Nodules. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. Jeffrey I. Stewart participate in research or clinical trials?

Yes. Dr. Jeffrey I. Stewart has published 9 articles and abstracts on conditions like Emphysema. You can view a list of Dr. Jeffrey I. Stewart's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jeffrey I. Stewart accept my insurance?

Dr. Jeffrey I. Stewart accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 603-650-2929 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stewart's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile